Kava extract ingredients, (+)-methysticin and (±)-kavain inhibit voltage-operated na+-channels in rat CA1 hippocampal neurons

Neuroscience

Volumn 81, Issue 2, 1997, Pages 345-351

  Magura, E I ^a   Kopanitsa, M V ^a   Gleitz, J ^b   Peters, T ^b   Krishtal, O A ^a  

^a BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

( ) kavain; (+) methysticin; Hippocampal neurons; Kava pyrone; Piper methysticum; Sodium channels

Indexed keywords

KAVA EXTRACT; KAWAIN; METHYSTICIN; SODIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DATA ANALYSIS; ELECTRIC SHOCK; EPILEPSY; HIPPOCAMPUS; MEMBRANE POTENTIAL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SODIUM CURRENT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; NEURONS; NEUROPROTECTIVE AGENTS; PYRANS; PYRONES; RATS; RATS, WISTAR; SODIUM CHANNELS;

EID: 0031559922     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00177-2     Document Type: Article

References (25)

1. Backhauß C., Krieglstein J. Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents. Eur. J. Pharmac. 215:1992;265-269.
2. Bean B. P., Cohen C. J., Tsien R. W. Lidocaine block of cardiac sodium channels. J. gen. Physiol. 81:1983;613-642.
3. Cahalan M. D., Almers W. Block of sodium conductance and gating current in squid giant axons poisoned with quaternary strychnine. Biophys. J. 27:1979;57-74.
4. + channels: local anesthetics, antiarrythmics and anticonvulsants. Trends pharmac. Sci. 8:1987;57-65.
5. B and benzodiazepine binding sites in rodent brain. Pharmac. Toxicol. 71:1992;120-126.
6. Duffield P. H., Jamieson D. D., Duffield A. M. Effect of aqueous and lipid-soluble extracts of kava on the conditioned avoidance response in rats. Archs Int. Pharmacodyn. 301:1989;81-90.
7. +-channels in synaptosomes prepared from rat cerebral cortex. Neuropharmacology. 34:1995;1133-1138.
8. 2+ and glutamate-release of rat cerebrocortical synaptosomes. Neuropharmacology. 35:1996;179-186.
9. Hamill O. P., Marty A., Neher E., Sakmann B., Sigworth F. J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391:1981;85-100.
10. Hille B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug receptor reaction. J. gen. Physiol. 69:1977;497-515.
11. Hodgkin A. L., Huxley A. F. The dual effect of membrane potential on sodium conductance in the giant axon of Loligo. J. Physiol. 116:1952;497-506.
12. +-channel blockers in isolated Purkinje neurons of rat cerebellum. Neuroscience. 54:1993;575-585.
13. Kretzschmar R., Meyer H. J. Vergleichende untersuchungen über die anticonvulsive wirksamkeit der pyronverbindungen aus Piper methysticum FORST. Archs Int. Pharmacodyn. 177:1969;261-277.
14. Krishtal O. A., Marchenko S. M., Pidoplichko V. I. Receptor for ATP in the membrane of mammalian sensory neurones. Neurosci. Lett. 35:1983;41-45.
15. + channels must deactivate to recover from inactivation. Neuron. 12:1994;819-829.
16. Lebot V., Merlin M. and Lindstorm L. (1992) Kava. The Pacific Drug. pp. 119-174. Yale University Press, New Haven.
17. Meyer H. J. (1979) Pharmacology of kava. In Ethnopharmacologic Search for Psychoactive Drugs (eds Efron D. H., Holmstedt B. and Kline N. S.), pp. 133-140. Raven, New York.
18. 2+ channels in rat central neurons. Neuroscience. 70:1996;353-360.
19. + currents by benzocaine homologs. Biophys. J. 70:1996;194-201.
20. +-channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic and anticonvulsant drugs. Molec. Pharmac. 40:1991;756-765.
21. Saletu B., Grünberger J., Linzmayer L., Anderer P. EEG-brain mapping, psychometric and psychophysiological studies on central effects of kavain-A kava plant derivative. Human Psychopharmac. 4:1989;169-190.
22. Schmitz D., Zhang C. L., Chatterjee S. S. Effects of methysticin on three different models of seizure like events studied in rat hippocampal and entorhinal cortex slices. Naunyn-Schmiedeberg's Arch. Pharmac. 351:1995;348-355.
23. Singh Y. N. Kava: an overview. J. Ethnopharmacol. 37:1992;13-45.
24. +-channels as targets for neuroprotective drugs. Trends pharmac. Sci. 16:1995;309-316.
25. + channels: a rational and effective strategy against ischemic brain damage. Pharmac. Rev. 48:1996;21-67.